603590 康辰药业
已收盘 08-16 15:00:00
资讯
新帖
简况
8月16日康辰药业涨5.99%，东兴连众一年持有期混合A基金重仓该股
证券之星 · 16:12
8月16日康辰药业涨5.99%，东兴连众一年持有期混合A基金重仓该股
康辰药业涨5.99%，首创证券二个月前给出“买入”评级
证券之星 · 16:12
康辰药业涨5.99%，首创证券二个月前给出“买入”评级
康辰药业（603590）8月16日主力资金净买入477.31万元
证券之星 · 15:11
康辰药业（603590）8月16日主力资金净买入477.31万元
康辰药业大幅上涨 获北向资金连续3日减持
智选洞察 · 14:30
康辰药业大幅上涨 获北向资金连续3日减持
北向资金8月15日净卖出康辰药业8.61万股 连续3日减持
自选股智能写手 · 09:30
北向资金8月15日净卖出康辰药业8.61万股 连续3日减持
康辰药业大幅上涨 获北向资金减持11.74万股
智选洞察 · 08-15 09:30
康辰药业大幅上涨 获北向资金减持11.74万股
康辰药业：KC1036治疗晚期食管鳞癌关键性Ⅲ期临床研究已于2024年2月完成首例受试者入组
每日经济新闻 · 08-09
康辰药业：KC1036治疗晚期食管鳞癌关键性Ⅲ期临床研究已于2024年2月完成首例受试者入组
康辰药业：目前公司经营稳健，在研项目在有序推进，公司将于8月28日披露2024年半年报
每日经济新闻 · 08-09
康辰药业：目前公司经营稳健，在研项目在有序推进，公司将于8月28日披露2024年半年报
北向资金8月8日净卖出康辰药业24.13万股 连续3日减持
自选股智能写手 · 08-09
北向资金8月8日净卖出康辰药业24.13万股 连续3日减持
康辰药业08月08日获主力加仓808万元 环比增加301.99%
自选股智能写手 · 08-08
康辰药业08月08日获主力加仓808万元 环比增加301.99%
生物制品行业盘中拉升，康辰药业涨3.56%
自选股智能写手 · 08-08
生物制品行业盘中拉升，康辰药业涨3.56%
康辰药业创1月新高 创新药政策利好落地
智选洞察 · 08-08
康辰药业创1月新高 创新药政策利好落地
康辰药业08月01日主力资金流入81万元 连续5日加仓
自选股智能写手 · 08-01
康辰药业08月01日主力资金流入81万元 连续5日加仓
中航证券：给予康辰药业买入评级
证券之星 · 08-01
中航证券：给予康辰药业买入评级
康辰药业最新公告：孙玉萍辞任董秘兼财务总监职务
证券之星 · 07-31
康辰药业最新公告：孙玉萍辞任董秘兼财务总监职务
7月31日康辰药业涨5.58%，东兴连众一年持有期混合A基金重仓该股
证券之星 · 07-31
7月31日康辰药业涨5.58%，东兴连众一年持有期混合A基金重仓该股
康辰药业(603590.SH)：孙玉萍辞任董秘兼财务总监职务
智通财经 · 07-31
康辰药业(603590.SH)：孙玉萍辞任董秘兼财务总监职务
【康辰药业(603590.SH)：孙玉萍辞任董秘兼财务总监职务】智通财经APP讯，康辰药业(603590.SH)公告，公司董事会近日收到公司董事会秘书兼财务总监孙玉萍提交的书面辞任报告。
智通财经 · 07-31
【康辰药业(603590.SH)：孙玉萍辞任董秘兼财务总监职务】智通财经APP讯，康辰药业(603590.SH)公告，公司董事会近日收到公司董事会秘书兼财务总监孙玉萍提交的书面辞任报告。
康辰药业大幅上涨 ZY5301临床研究结果获国际认可
智选洞察 · 07-31
康辰药业大幅上涨 ZY5301临床研究结果获国际认可
康辰药业07月30日主力资金流入49万元 连续3日加仓
自选股智能写手 · 07-30
康辰药业07月30日主力资金流入49万元 连续3日加仓
公司概况
公司名称：
北京康辰药业股份有限公司
所属行业：
医药制造业
上市日期：
2018-08-27
主营业务：
北京康辰药业股份有限公司的主营业务是一家坚持以创新药研发为核心、以临床需求为导向，集研发、生产和销售于一体。目前公司产品和在研产品主要专注于血液、骨科以及肿瘤等市场空间较大的领域。公司主要产品“苏灵”是目前国内血凝酶制剂市场唯一的国家一类新药。
发行价格：
24.34
{"stockData":{"symbol":"603590","market":"SH","secType":"STK","nameCN":"康辰药业","latestPrice":25.5,"timestamp":1723791600000,"preClose":24.06,"halted":0,"volume":3867311,"delay":0,"floatShares":158000000,"shares":160000000,"eps":1.0403,"marketStatus":"已收盘","marketStatusCode":5,"change":1.44,"latestTime":"08-16 15:00:00","open":23.8,"high":25.97,"low":23.32,"amount":95519000,"amplitude":0.1101,"askPrice":25.7,"askSize":14,"bidPrice":25.5,"bidSize":4,"shortable":0,"etf":0,"ttmEps":1.0403,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724031000000},"adr":0,"adjPreClose":24.06,"symbolType":"stock","openAndCloseTimeList":[[1723771800000,1723779000000],[1723784400000,1723791600000]],"highLimit":26.47,"lowLimit":21.65,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":160000000,"pbRate":1.3,"roa":"--","roe":"1.34%","epsLYR":0.96,"committee":-0.229814,"marketValue":4080000000,"floatMarketCap":4017000000,"peRate":24.51216,"changeRate":0.0599,"turnoverRate":0.0246,"status":0},"requestUrl":"/m/hq/s/603590/wiki","defaultTab":"wiki","newsList":[{"id":"2459264708","title":"8月16日康辰药业涨5.99%，东兴连众一年持有期混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2459264708","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459264708?lang=zh_cn&edition=full","pubTime":"2024-08-16 16:12","pubTimestamp":1723795953,"startTime":"0","endTime":"0","summary":"证券之星消息，8月16日康辰药业涨5.99%，收盘报25.5元，换手率2.46%，成交量3.87万手，成交额9551.9万元。重仓康辰药业的公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级2家，增持评级1家。根据2024基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为东兴连众一年持有期混合A。东兴连众一年持有期混合A目前规模为1.68亿元，最新净值0.9814，较上一交易日上涨0.02%，近一年下跌1.48%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081600031784.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603590","BK0239"],"gpt_icon":0},{"id":"2459264740","title":"康辰药业涨5.99%，首创证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2459264740","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459264740?lang=zh_cn&edition=full","pubTime":"2024-08-16 16:12","pubTimestamp":1723795948,"startTime":"0","endTime":"0","summary":"今日康辰药业涨5.99%，收盘报25.5元。2024年5月22日，首创证券研究员王斌发布了对康辰药业的研报《公司简评报告：核心产品快速增长，创新药研发持续突破》，该研报对康辰药业给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为71.12%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为东方证券的田世豪。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081600031778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601136","603590"],"gpt_icon":0},{"id":"2459265421","title":"康辰药业（603590）8月16日主力资金净买入477.31万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459265421","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459265421?lang=zh_cn&edition=full","pubTime":"2024-08-16 15:11","pubTimestamp":1723792303,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月16日收盘，康辰药业报收于25.5元，上涨5.99%，换手率2.46%，成交量3.87万手，成交额9551.9万元。康辰药业主营业务：公司是一家以创新药研发为核心、以临床需求为导向,集研发、生产和销售于一体的创新型制药企业。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081600025606.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603590"],"gpt_icon":0},{"id":"2459526847","title":"康辰药业大幅上涨 获北向资金连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2459526847","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459526847?lang=zh_cn&edition=full","pubTime":"2024-08-16 14:30","pubTimestamp":1723789818,"startTime":"0","endTime":"0","summary":"08月16日，康辰药业股价大幅上涨，截至14点30分，康辰药业上涨5.07%，报25.28元/股，成交6571万元，换手率1.72%。资金动向截止发稿，康辰药业获得主力净流出110万元，其中超大单流出261万元，大单流入152万元。北向资金方面，康辰药业08月15日获得北向资金减持8.61万股连续3日减持，截至08月15日，北向资金当前共持有康辰药业23.74万股，市值600万元，持股占流通股比为0.15%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816143121ab5dfbab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816143121ab5dfbab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603590","BK0239"],"gpt_icon":0},{"id":"2459236030","title":"北向资金8月15日净卖出康辰药业8.61万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2459236030","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459236030?lang=zh_cn&edition=full","pubTime":"2024-08-16 09:30","pubTimestamp":1723771830,"startTime":"0","endTime":"0","summary":"8月15日，北向资金减持康辰药业8.61万股连续3日减持。截止当日收盘，沪股通共持有康辰药业23.74万股，占流通股0.15%。沪股通减持金额前五个股分别为上海贝岭、XD工业富、中国核电、韦尔股份、金龙汽车。康辰药业近5个交易日下跌2.75%，沪股通累计减持5.15万股；近20个交易日下跌3.61%，沪股通累计减持13.82万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816093434959cf109&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816093434959cf109&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603590","BK0239"],"gpt_icon":0},{"id":"2459546880","title":"康辰药业大幅上涨 获北向资金减持11.74万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2459546880","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459546880?lang=zh_cn&edition=full","pubTime":"2024-08-15 09:30","pubTimestamp":1723685459,"startTime":"0","endTime":"0","summary":"资金动向截止发稿，康辰药业获得主力净流入29万元，其中超大单流出136万元，大单流入165万元。北向资金方面，康辰药业08月14日获得北向资金减持11.74万股，截至08月14日，北向资金当前共持有康辰药业32.35万股，市值815万元，持股占流通股比为0.20%。最新财报显示，今年一季报，康辰药业实现营业收入1.99亿元，同比增长20.67%，净利润为4,165.43万元，同比增长62.28%，基本每股收益为0.27元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815093251aefec80b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815093251aefec80b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603590","BK0239"],"gpt_icon":0},{"id":"2458558924","title":"康辰药业：KC1036治疗晚期食管鳞癌关键性Ⅲ期临床研究已于2024年2月完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2458558924","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458558924?lang=zh_cn&edition=full","pubTime":"2024-08-09 15:43","pubTimestamp":1723189386,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：你好，请问公司自主研发首创新药kc1036在食道癌领域是否属于突破性治疗品种？康辰药业（603590.SH）8月8日在投资者互动平台表示， KC1036治疗晚期食管鳞癌关键性Ⅲ期临床研究已于2024年2月完成首例受试者入组，目前进展顺利，公司将按国家有关规定，积极推进药物研发进度，并根据研发进展情况及时履行信息披露义务。(记者 蔡鼎)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809154358958b258f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809154358958b258f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603590","BK0239"],"gpt_icon":0},{"id":"2458589275","title":"康辰药业：目前公司经营稳健，在研项目在有序推进，公司将于8月28日披露2024年半年报","url":"https://stock-news.laohu8.com/highlight/detail?id=2458589275","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458589275?lang=zh_cn&edition=full","pubTime":"2024-08-09 15:42","pubTimestamp":1723189361,"startTime":"0","endTime":"0","summary":"给热爱你们公司的中小股东一丝持股信心，谢谢康辰药业8月8日在投资者互动平台表示，目前公司经营稳健，在研项目在有序推进，公司将于8月28日披露2024年半年度报告，敬请关注。二级市场股价受宏观经济、行业政策、市场波动等多重因素影响。公司一直注重提升经营业绩水平，持续做好生产经营活动，积极推动业务发展；公司长期专注于自主创新，打造新的竞争力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809154333958b254f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809154333958b254f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603590"],"gpt_icon":0},{"id":"2458830170","title":"北向资金8月8日净卖出康辰药业24.13万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2458830170","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458830170?lang=zh_cn&edition=full","pubTime":"2024-08-09 09:30","pubTimestamp":1723167032,"startTime":"0","endTime":"0","summary":"8月8日，北向资金减持康辰药业24.13万股连续3日减持。截止当日收盘，沪股通共持有康辰药业28.89万股，占流通股0.18%。沪股通减持金额前五个股分别为中国核电、中国石油、海尔智家、招商银行、韦尔股份。康辰药业近5个交易日上涨4.83%，沪股通累计减持21.44万股；近20个交易日下跌1.24%，沪股通累计减持11.24万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408090934379f1bfd13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408090934379f1bfd13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603590","BK0239"],"gpt_icon":0},{"id":"2457352623","title":"康辰药业08月08日获主力加仓808万元 环比增加301.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457352623","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457352623?lang=zh_cn&edition=full","pubTime":"2024-08-08 15:18","pubTimestamp":1723101534,"startTime":"0","endTime":"0","summary":"08月08日, 康辰药业股价涨2.53%，报收24.74元，成交金额6477万元，换手率1.66%，振幅6.13%，量比2.34。康辰药业今日主力资金净流入808万元，上一交易日主力净流入201万元，今日环比增加301.99%。|08月08日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|民生健康|7.46%|#|C龙图|5.30%|#|塞力医疗|4.83%|#|超频三|4.44%|#|诺瓦星云|4.29%|#|亚振家居|3.89%|#|正虹科技|3.89%|#|华东数控|3.88%|#|神农种业|3.88%|#|潍柴重机|2.83%|康辰药业所在的生物制品行业，今日主力净流入1510万元，行业排名38/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408081532509f19a648&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408081532509f19a648&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603590","BK0239"],"gpt_icon":0},{"id":"2457960333","title":"生物制品行业盘中拉升，康辰药业涨3.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457960333","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457960333?lang=zh_cn&edition=full","pubTime":"2024-08-08 11:06","pubTimestamp":1723086375,"startTime":"0","endTime":"0","summary":"08月08日，生物制品行业盘中拉升，截至11点06分，生物制品行业整体指数上涨0.52%，报5820.120点。从个股上来看，该行业的成分股中，康辰药业涨3.56%，优宁维、博雅生物、金迪克涨幅居前。从资金上来看，截止发稿，生物制品行业主力净流入为2151.91万，其中四环生物受到资金热捧，主力净流入1235.18万；拉长时间线来看，该板块近20日主力资金净流入-15.58亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808110615aefdd6ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808110615aefdd6ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603590"],"gpt_icon":0},{"id":"2457387612","title":"康辰药业创1月新高 创新药政策利好落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2457387612","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457387612?lang=zh_cn&edition=full","pubTime":"2024-08-08 10:05","pubTimestamp":1723082749,"startTime":"0","endTime":"0","summary":"从政策面来看，2024年以来创新药政策支持态度逐步明确，政策利好不断落地。此外，各大药企也在纷纷布局肺癌创新药研发。北向资金方面，康辰药业08月07日获得北向资金减持7.12万股，截至08月07日，北向资金当前共持有康辰药业53.02万股，市值1346万元，持股占流通股比为0.33%。主营业务及业绩康辰药业公司主营业务为以创新药研发为核心、以临床需求为导向，集研发、生产和销售于一体。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808100746af9682ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808100746af9682ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603590","BK0239","159992"],"gpt_icon":0},{"id":"2456176623","title":"康辰药业08月01日主力资金流入81万元 连续5日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2456176623","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456176623?lang=zh_cn&edition=full","pubTime":"2024-08-01 15:19","pubTimestamp":1722496770,"startTime":"0","endTime":"0","summary":"08月01日, 康辰药业股价跌1.05%，报收23.60元，成交金额2573万元，换手率0.69%，振幅4.49%，量比1.20。康辰药业今日主力资金净流入81万元，连续5日净流入，上一交易日主力净流入66万元，今日环比增加22.73%。近一年数据显示，该股主力连续5日净流入后，次日上涨概率为66.67%，平均涨幅为0.63%。该股近5个交易日上涨3.15%，主力资金累计净流入408万元，其中3个交易日为股价下跌时净流入；近20日主力资金累计净流入707万元，其中净流入天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408011532159f04a5fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408011532159f04a5fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603590"],"gpt_icon":0},{"id":"2456187181","title":"中航证券：给予康辰药业买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2456187181","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456187181?lang=zh_cn&edition=full","pubTime":"2024-08-01 07:30","pubTimestamp":1722468637,"startTime":"0","endTime":"0","summary":"中航证券李蔚近期对康辰药业进行研究并发布了研究报告《ZY5301临床结果于JAMA期刊发表，看好后续研发进展》，本报告对康辰药业给出买入评级，当前股价为23.85元。最新盈利预测明细如下：该股最近90天内共有3家机构给出评级，买入评级2家，增持评级1家；过去90天内机构目标均价为43.33。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080100011993.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603590","161027"],"gpt_icon":0},{"id":"2455909875","title":"康辰药业最新公告：孙玉萍辞任董秘兼财务总监职务","url":"https://stock-news.laohu8.com/highlight/detail?id=2455909875","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455909875?lang=zh_cn&edition=full","pubTime":"2024-07-31 16:52","pubTimestamp":1722415929,"startTime":"0","endTime":"0","summary":"康辰药业公告，公司董事会近日收到董事会秘书兼财务总监孙玉萍提交的书面辞任报告。孙玉萍因个人原因申请辞去公司董事会秘书兼财务总监职务，该辞任报告自送达董事会之日起生效。孙玉萍辞去上述职务后，将在公司担任其他职务。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073100034474.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603590","BK0239"],"gpt_icon":0},{"id":"2455034409","title":"7月31日康辰药业涨5.58%，东兴连众一年持有期混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2455034409","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455034409?lang=zh_cn&edition=full","pubTime":"2024-07-31 16:26","pubTimestamp":1722414406,"startTime":"0","endTime":"0","summary":"证券之星消息，7月31日康辰药业涨5.58%创60日新低，收盘报23.85元，换手率0.89%，成交量1.41万手，成交额3287.45万元。根据2024基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为东兴连众一年持有期混合A。东兴连众一年持有期混合A目前规模为1.68亿元，最新净值0.982，较上一交易日上涨0.01%，近一年下跌1.83%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073100033306.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603590"],"gpt_icon":0},{"id":"2455972537","title":"康辰药业(603590.SH)：孙玉萍辞任董秘兼财务总监职务","url":"https://stock-news.laohu8.com/highlight/detail?id=2455972537","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455972537?lang=zh_cn&edition=full","pubTime":"2024-07-31 15:33","pubTimestamp":1722411225,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康辰药业(603590.SH)公告，公司董事会近日收到公司董事会秘书兼财务总监孙玉萍提交的书面辞任报告。孙玉萍因个人原因申请辞去公司董事会秘书兼财务总监职务，该辞任报告自送达董事会之日起生效。孙玉萍辞去上述职务后，将在公司担任其他职务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1157910.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","603590"],"gpt_icon":0},{"id":"2455097255","title":"【康辰药业(603590.SH)：孙玉萍辞任董秘兼财务总监职务】智通财经APP讯，康辰药业(603590.SH)公告，公司董事会近日收到公司董事会秘书兼财务总监孙玉萍提交的书面辞任报告。","url":"https://stock-news.laohu8.com/highlight/detail?id=2455097255","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455097255?lang=zh_cn&edition=full","pubTime":"2024-07-31 15:33","pubTimestamp":1722411225,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["603590","BK0239"],"gpt_icon":0},{"id":"2455924863","title":"康辰药业大幅上涨 ZY5301临床研究结果获国际认可","url":"https://stock-news.laohu8.com/highlight/detail?id=2455924863","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455924863?lang=zh_cn&edition=full","pubTime":"2024-07-31 13:01","pubTimestamp":1722402119,"startTime":"0","endTime":"0","summary":"消息解读康辰药业公告，ZY5301是公司拥有自主知识产权的中药创新药，聚焦于治疗女性盆腔炎性疾病后遗症慢性盆腔痛的临床研究。近期，ZY5301 Ⅱ期临床研究结果在经多位国际评审专家严苛审评后，《JAMA Network Open》正式接受并刊出。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731130802af95043a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731130802af95043a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603590","BK0239"],"gpt_icon":0},{"id":"2455778606","title":"康辰药业07月30日主力资金流入49万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2455778606","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455778606?lang=zh_cn&edition=full","pubTime":"2024-07-30 15:25","pubTimestamp":1722324307,"startTime":"0","endTime":"0","summary":"07月30日, 康辰药业股价跌0.31%，报收22.59元，成交金额1786万元，换手率0.50%，振幅1.50%，量比0.95。康辰药业今日主力资金净流入49万元，连续3日净流入，上一交易日主力净流入190万元，今日环比减少74.21%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为66.67%，平均涨幅为1.56%。该股近5个交易日下跌3.13%，主力资金累计净流入242万元；近20日主力资金累计净流入771万元，其中净流入天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730153214956ba25f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730153214956ba25f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603590","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2018-08-27","address":"北京市密云区经济开发区兴盛南路11号","stockEarnings":[{"period":"1week","weight":-0.0275},{"period":"1month","weight":-0.0204},{"period":"3month","weight":-0.2034},{"period":"6month","weight":-0.1602},{"period":"1year","weight":-0.2922},{"period":"ytd","weight":-0.3605}],"companyName":"北京康辰药业股份有限公司","boardCode":"AI0027","perCapita":"13836股","boardName":"医药制造业","registeredCapital":"16000万元","compareEarnings":[{"period":"1week","weight":0.0026},{"period":"1month","weight":-0.0332},{"period":"3month","weight":-0.0877},{"period":"6month","weight":0.004},{"period":"1year","weight":-0.0866},{"period":"ytd","weight":-0.0328}],"survey":" 北京康辰药业股份有限公司的主营业务是一家坚持以创新药研发为核心、以临床需求为导向，集研发、生产和销售于一体。目前公司产品和在研产品主要专注于血液、骨科以及肿瘤等市场空间较大的领域。公司主要产品“苏灵”是目前国内血凝酶制剂市场唯一的国家一类新药。","serverTime":1723811335459,"listedPrice":24.34,"stockholders":"11384人(较上一季度增加4.85%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康辰药业(603590)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康辰药业(603590)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康辰药业,603590,康辰药业股票,康辰药业股票老虎,康辰药业股票老虎国际,康辰药业行情,康辰药业股票行情,康辰药业股价,康辰药业股市,康辰药业股票价格,康辰药业股票交易,康辰药业股票购买,康辰药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康辰药业(603590)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康辰药业(603590)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}